News

  1. Home
  2. About
17 September 2019

Advances in breast cancer research

Advances in breast cancer research

A research group has identified changes in tumor cell metabolism during the evolution of breast carcinoma that may open doors to understanding the various stages of evolution of this disease to more aggressive stages and ultimately to more effective treatments. The study, presented at the international meeting “2019 Advanced Course in Oncometabolism: From Conceptual Knowledge to Clinical Applications” in early September in Luso, was awarded the third best poster award.

These results contribute to unravel the metabolic pathways in the progression of luminal breast carcinoma leading to the formation of tumors with resistance to antitumor therapy. This is achieved by measuring a large number of types and quantities of compounds, or metabolites (a strategy called Metabolomics), which may characterize the various stages of carcinoma progression. Most cases of breast cancer are dependent on ovarian hormones and about half of them develop resistance to first-line therapies (hormone therapy) aimed at blocking the effects of these hormones, although patients may be treated with other therapies (second-line therapy).

Metabolic changes were identified in this work using Nuclear Magnetic Resonance (NMR) spectroscopy to measure mammary tumor metabolites obtained from a mice model. The animal model used as part of a collaboration with a Buenos Aires group (led by Claudia Lanari) very closely illustrates the progression of hormone-dependent breast cancer in humans, says Rita Araújo, the study's first author and PhD student, including the development of resistance to endocrine therapy. This PhD student in NMR applied to Chemistry, Materials, Biosciences, funded by the Portuguese NMR Network (PTNMR), is under the supervision of Ana Gil, professor in the Department of Chemistry of the UA and researcher at CICECO, and co-supervision of Luisa Helguero, Professor in the Department of Medical Sciences and Researcher, UA Institute of Biomedicine (iBIMED).

The next step in the study will be to evaluate which metabolic pathways are altered when tumors acquire resistance to therapy, in order to investigate how resistant cells may overcome the effects induced by therapy and, thus, reverse (at least in part) therapy resistance. The metabolic profiles of several organs of the same animals will be analyzed to evaluate the overall behavior of the organism (including the presence of metastases) in each stage of tumoral progression. At a later stage, results will need to be confirmed in human tumors so that biomarkers of hormone therapy resistence and response may be proposed.

More information: https://oncometabolism2019.febsevents.org/

Share this Article:

Related Articles

Researchers

Groups

5 - biomedical and biomimetic materials

We use cookies for marketing activities and to offer you a better experience. By clicking “Accept Cookies” you agree with our cookie policy. Read about how we use cookies by clicking "Privacy and Cookie Policy".


Privacy and Cookie Policy

Personal data

CICECO-Aveiro Institute of Materials respects your privacy, ensuring confidentiality of personal data you share with the institution through this way, not collecting any personal information about you without your consent, under the terms required by General Data Protection Regulations (RGPD).

The data collected in forms are intended exclusively for processing user requests and will not be used for any other purpose, always safeguarding their confidentiality, under the terms of the protection conferred by the aforementioned regulation.

The collection and processing of data is the responsibility of CICECO and its storage is properly protected, only authorized CICECO employees can access the information within the scope of their functions, always being clear in the respective collection forms the purposes for which they are intended. The remaining issues to be considered in this matter will be handled by the University of Aveiro in accordance with the regime established by the GDPR.

Cookies policy

Cookies are small files with alphanumeric information that are stored on your computer's hard drive by your browser and are intended to improve the user experience and enhance website navigation.

Collection and use of technical information

The cookies used on CICECO are anonymous, and no information about our users that allows their personal identification is stored in them.

The technical information recorded consists of:

  • iP (Internet Protocol) address of the visitor;
  • the type of internet browser used by the website visitor and the respective operating system used;
  • the date and time of the consultation;
  • the pages visited on the site and the documents downloaded
  • The technical information collected is used for statistical purposes only.

Cookies used

Session cookies

These cookies are used to record user preferences, such as the language in which websites are displayed or to maintain authenticated user sessions, and are automatically deleted when the browser is closed.

Persistent cookies

These cookies store information that is needed between sessions. For example, a persistent cookie is set to record that you have been made aware of the cookie policy so that the message regarding this policy is not shown again the next time you visit the website. This cookie remains on the computer until it reaches its expiry date or is deleted by the user.

Data protection

The present privacy policy covers the Information System of the University of Aveiro (SIUA), governed by the General Data Protection Regulations (RGPD) Regulation (EU) No. 2016/679, of April 27th, 2016.

Data Protection Officer

The University of Aveiro has a Data Protection Officer (DPO), who ensures compliance of the processing of personal data with the legislation in force, and is available through the following email address epd@ua.pt.

Close